# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-093959
Filing Date
2023-04-06
Accepted
2023-04-06 16:04:56
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | d441502ddefa14a.htm | DEFA14A | 18617
2 | GRAPHIC | g441502g77d43.jpg | GRAPHIC | 333377
3 | GRAPHIC | g441502g95b07.jpg | GRAPHIC | 370560
| Complete submission text file | 0001193125-23-093959.txt |  | 989536

Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37702 | Film No.: 23806173
SIC: 2836 Biological Products, (No Diagnostic Substances)